A recent investigation found that high LGR5 protein levels in estrogen-negative (ER-) breast cancer were associated with reduced recurrence-free survival and OS, but interestingly, high LGR5 levels in ER + breast cancers were associated with better outcomes [70]. The gene discussed is LGR5; the disease is breast carcinoma.